ELEMENTS (5246) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 Apr, 2026Executive summary
Positioned FY2026/11 as a ramp-up period for maximizing mid- to long-term profit growth, with continued investment and business expansion initiatives.
Achieved record quarterly revenue of ¥1,291.9 million, up 80.6% year-over-year, driven by strong LIQUID eKYC performance, Polarify consolidation, and AI cloud platform demand.
Operating profit reached ¥119.7 million (up from a loss YoY), EBITDA ¥269 million (up ¥178 million YoY), and net income attributable to parent ¥100.2 million, all returning to profitability.
The company continues to expand its core AI cloud platform, driven by digital transformation and regulatory changes boosting the eKYC market.
Financial highlights
Revenue: ¥1,291.9 million (+80.6% YoY), gross profit: ¥980.7 million (+55% YoY), gross margin: 76% (down from 88.7% YoY due to Polarify consolidation).
SG&A expenses rose 33% YoY to ¥860 million, mainly from Polarify-related costs, but SG&A-to-sales ratio improved to 66.6% (down 24 pts YoY).
EBITDA: ¥269 million (+196% YoY), operating profit: ¥119.7 million (vs. -¥13 million YoY), net income: ¥100.2 million (vs. -¥51.8 million YoY).
Operating profit margin improved to 9.3% from a negative margin last year.
Total assets at quarter-end were ¥6,957.9 million, down ¥282.1 million from the previous year-end.
Outlook and guidance
FY2026/11 full-year revenue guidance: ¥5,100–5,300 million (+30% YoY), EBITDA: ¥800–1,000 million, operating profit: ¥0–200 million (return to operating profit).
Net income forecast for the year is between a loss of ¥100 million and a profit of ¥100 million.
Continued investment in eKYC and authentication solutions, with focus on expanding market share and launching new AI-driven services.
No dividend is planned for the fiscal year.
Latest events from ELEMENTS
- Revenue up 53%, net loss widened; FY26 targets profitability and strong authentication growth.5246
Q4 202513 Jan 2026 - Record revenue growth offset by higher costs and net loss; outlook remains unchanged.5246
Q3 202514 Oct 2025 - Record revenue growth offset by a large impairment-driven net loss and revised outlook.5246
Q2 202514 Jul 2025 - Revenue up 41%, EBITDA positive, and capital strengthened after Admedica acquisition.5246
Q3 202413 Jun 2025 - Revenue and EBITDA rose sharply, guidance raised, and capital structure strengthened.5246
Q2 202413 Jun 2025 - Revenue up 66% YoY, EBITDA positive, but net loss widened as Polarify was acquired.5246
Q1 20256 Jun 2025 - Record revenue, first full-year profit, and Polarify deal set stage for future growth.5246
Q4 20246 Jun 2025